Revance to Present Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Fillers at American Academy of Dermatology VMX Meeting 2021
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Revance to Present Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Fillers at American Academy of Dermatology VMX Meeting 2021
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Search jobs Revance to Participate in the 20th Annual Needham Virtual Healthcare Conference
NASHVILLE, Tenn. (BUSINESS WIRE) Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the company will participate in the 20th Annual Needham Virtual Healthcare Conference, a fully virtual management access conference, taking place April 12-15.
President and Chief Executive Officer, Mark Foley, is scheduled to participate in a fireside chat on Tuesday, April 13, at 7:15 a.m. PT / 10:15 a.m. ET.
Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company s website at www.revance.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.